Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.89B
+13.4% from 2023
Prescriptions
1.3M
$1,509.98 per claim
Patients
310K
125,776 prescribers
Total spending, 2024
$1.89B
$6,097.18 per patient
Medicare prescription drug plans paid $1.89B for Rybelsus in 2024, for 1,251,182 prescriptions and refills to 309,850 patients (up 13.4% from 2023). The average cost per claim was $1,509.98.
California had the highest Medicare cost for Rybelsus in 2024: $229.4M for 157,307 claims, followed by New York ($171.6M).
Wei Y Sun, nephrology in New York, NY, had the highest Medicare cost for Rybelsus in 2024: 853 claims costing $872K.
Rybelsus is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Wei Y Sun New York, NY | Nephrology | 853 | 127 | $872K |
| Yun Feng New York, NY | Endocrinology | 719 | 142 | $856K |
| Duc H Phan Houston, TX |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 81,128 | 686,142 | 184,563 | $974.6M |
| 2023 | 114,075 | 1,074,653 | 285,571 | $1.67B |
| 2024 | 125,776 | 1,251,182 | 309,850 | $1.89B |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 521 |
| 123 |
| $812K |
| George C Liu New York, NY | Internal Medicine | 401 | 94 | $768K |
| Phong H Bui Fountain Valley, CA | Internal Medicine | 431 | 87 | $633K |
| Ivana Sheu San Francisco, CA | Endocrinology | 429 | 84 | $613K |
| Sharon H Kim Bronx, NY | Endocrinology | 364 | 76 | $592K |
| Eliscer Guzman New York, NY | Internal Medicine | 377 | 97 | $563K |
| Bao Q Nguyen Stockton, CA | Family Practice | 581 | 69 | $561K |
| Zihe Shan Brooklyn, NY | Internal Medicine | 297 | 70 | $541K |
| Michael W Lin San Gabriel, CA | Endocrinology | 402 | 79 | $535K |
| Sheikh M Masood Madera, CA | Nephrology | 525 | 109 | $518K |
| Isaiah Pittman IV Terre Haute, IN | Endocrinology | 374 | 112 | $489K |
| Rodolfo Guzman Bronx, NY | Endocrinology | 296 | 67 | $480K |
| Bashar G Saad San Dimas, CA | Endocrinology | 323 | 101 | $475K |
| Tu N Truong San Diego, CA | Internal Medicine | 267 | 68 | $473K |
| Jerry L Jurado Union City, NJ | Family Practice | 212 | 65 | $472K |
| Manavendra Bakhshi Philadelphia, PA | Cardiology | 407 | 68 | $470K |
| Kathrine A Gold Brooklyn, NY | Internal Medicine | 269 | 66 | $469K |
| Enrique J Griego McAllen, TX | Family Practice | 281 | 94 | $463K |
| Dinorah J Nutis El Paso, TX | Internal Medicine | 204 | 64 | $428K |
| Ashvin Vijayakumar Philadelphia, PA | Hospitalist | 378 | 51 | $405K |
| Shailesh Baral York, PA | Endocrinology | 265 | 71 | $404K |
| Fufu He Brooklyn, NY | Family Practice | 266 | 45 | $399K |
| Bosheng Qiu Alhambra, CA | Internal Medicine | 379 | 61 | $385K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novo Nordisk NVO | 1,251,733 | $1.89B |